Medical Device News Magazine

CIONIC Unveils Three New Centers of Excellence on the East Coast to Aid Patient Mobility Through the Use of FDA-Cleared Bionic Clothing and Neuromodulation

Cionic Neural Sleeve Now Available at Leading Medical Institutions International Multiple Sclerosis Management Practice, MedStar Health, and Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

CIONIC, the pioneering neurotech company that created the FDA-cleared Cionic Neural Sleeve, today announced three new Centers of Excellence at renowned institutions including International Multiple Sclerosis Management Practice (IMSMP) in New York City, Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center’s MS Center in Neptune, NJ, and MedStar Health with centers across Maryland, Virginia, and Washington, D.C.

CIONIC, in collaboration with qualified clinicians at the Centers of Excellence, utilizes the Neural Sleeve and proprietary neuromodulation platform to deliver a seamless care experience from the clinical environment to the home or community setting. The Neural Sleeve is the first bionic clothing that analyzes and augments human movement, enabling individuals with multiple sclerosis, stroke, spinal cord injuries, and other neurologic diagnoses to move with more freedom and control.

Individuals interested in experiencing the Neural Sleeve can contact their doctor at these Centers of Excellence to make an appointment to try the Neural Sleeve, or contact CIONIC directly at https://cionic.com/coe. The Cionic Neural Sleeve is a mobility aid that is available by prescription only.

“Digital therapeutics are set to transform healthcare, not only through continuous monitoring of patient metrics, but also by delivering real-time care personalized to individual needs. This will only happen through deep collaboration with healthcare providers,” said Jeremiah Robison, CIONIC Founder & CEO. “We are proud to work with IMSMP, Jersey Shore University Medical Center, and MedStar Health to deliver a unified care experience with the Neural Sleeve from the clinic to the home, setting a new standard for mobility care.”

“For over sixty years, IMSMP has provided individuals living with multiple sclerosis industry-leading care that prioritizes access to the latest research,” said Dr. Saud Sadiq, Medical Director of IMSMP. “Our comprehensive, holistic approach addresses the full continuum of care, which includes making the most advanced technology available to our patients and empowering them to live full and independent lives.” Together with partner organization Tisch MS Research Center of New York, their New York City-based facilities make up the largest independently-funded MS center in the world.

“The work we do at our MS Center focuses on providing care that addresses patient needs at every step of their journey with their illness, from diagnosis through treatment,” said David Duncan, M.D., medical director of the MS Center at Jersey Shore University Medical Center, a National Multiple Sclerosis Society designated Center for Comprehensive MS Care. “By integrating innovative technologies like the Neural Sleeve into patient care, we deliver on our commitment to providing the full breadth of resources available to assist our patients with living active and healthy lives.”

CIONIC Centers of Excellence are leading neurological rehabilitation centers that represent the gold standard for patient care. In strategic collaboration with these centers, patients will have an opportunity to experience the Cionic Neural Sleeve under the guidance and expertise of staff. Current Centers of Excellence include Shirley Ryan AbilityLab, the number-one ranked rehabilitation hospital in the country, according to U.S. News & World Report, UCHealth University of Colorado Hospital, the region’s largest adult academic medical center, Craig Hospital, a world-renowned rehabilitation hospital that exclusively specializes in neurorehabilitation, and Neuro Physical Therapy, a distinguished physical therapy practice.

How the Cionic Neural Sleeve Works

Backed by clinical evidence and FDA-cleared, the award-winning Cionic Neural Sleeve analyzes, predicts, and augments an individual’s movement. It uses a dense array of sensors to measure the firing patterns of individual muscles and the resultant position of the leg during movement. Algorithms running on the sleeve analyze this data in real-time to predict intended movement and determine optimal muscle activation patterns. The Cionic Neural Sleeve then delivers Functional Electrical Stimulation to sequence proper muscle firing for natural movement. It is an adaptive system that provides real-time augmentation and adjustment of the wearer’s movement, updating each time they take a step. The Cionic Neural Sleeve has been recognized in numerous global design and healthcare competitions, including TIME Best Inventions, the Digital Health Hub Awards, Fierce Life Sciences Innovation Awards, Fast Company World Changing Ideas, MedTech Innovation Awards, International Design Excellence Awards, iF DESIGN AWARD, Edison Awards, and more.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”